Highlights
- Delhivery has appointed Namita Thapar, Executive Director at Emcure Pharmaceuticals Limited, as a Non-Executive Independent Director on its Board effective February 17, 2025.
- Namita Thapar brings extensive experience from her role as Chief Executive Officer of Emcure Pharmaceuticals’ India Business, which generates an annual revenue of ₹ 8000 crore.
Delhivery has announced the appointment of Namita Thapar, Executive Director at Emcure Pharmaceuticals Limited as a Non-Executive Independent Director to the Board of the Company with effect from February 17, 2025.
According to the Companies Act 2013, a non-executive independent director refers to a director who is routinely involved in the day-to-day management of the company and has no personal or pecuniary relationship with the company; allowing them to undertake objective oversight and exercising the power with independence from the executive directors.
Namita is the Executive Director of Emcure Pharmaceuticals, a global pharmaceutical company headquartered in Pune. She is the Chief Executive Officer of their India Business grossing an annual revenue of ₹ 8000 cr.
Prior to joining the family business, Namita worked for 6 years at Guidant Corporation, USA, in their business finance team. Namita is an MBA graduate from the Fuqua School of Business at Duke University and a Chartered Accountant from ICAI.
She also stars as a “shark,” in the popular TV show “Shark Tank India“. Commenting on the appointment, Sahil Barua, Managing Director and CEO said, “We’re excited to bring Namita onboard. Her extensive experience in leading a high-growth business and innovating in a sector like healthcare brings a valuable perspective to our industry.
India’s logistics service provider provides a wide range of logistics services such as express parcel transportation, PTL freight, TL freight, cross-border, supply chain, and technology services.
